Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07332468 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Digital Remote Management for Care and Continuous Optimization Versus Usual Care to Reduce Risk of Atherosclerotic Cardiovascular Diseases (DigiCare-preASCVD)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 9 months later Mar 2027 → Jan 2028
Enrollment reduced 29% 790 → 564 participants
See other at-risk trials from Beijing Anzhen Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Mar 2027 to Jan 2028v2 Show 8 more changesShow less
    • Recruitment opened
    • Enrollment reduced: 790 → 564 participants
    • Study completion pushed from Apr 2027 to Apr 2028
    • Start date changed from estimate of Jan 2026 to Feb 25, 2026
    • Secondary endpoints: 6 to 8
    • Site details revised at 5 of 5 sites
    • Study title revised
    • Study description expanded, about 1 word
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The DigiCare-preASCVD study is an investigator-initiated, multicenter, open-label, parallel-group randomized controlled trial. It aims to evaluated whether digital remote management is superior to usual care in reducing risk of atherosclerotic cardiovascular diseases and improving blood pressure control, glycemic control, lipids control, medication compliance and lifestyle.
Trial Details
NCT Number NCT07332468
Lead Sponsor Beijing Anzhen Hospital
Conditions
(from sponsor)		 Atherosclerotic Cardiovascular Diseases
Enrollment 564 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov